Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection
NCT ID: NCT00841750
Last Updated: 2011-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
100 participants
INTERVENTIONAL
2008-07-31
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tubeless VATS for Peripheral Lung Nodule
NCT02817048
Risk of Pneumothorax With and Without Chest Tube Clamping in Patients With Pleural Pathology
NCT05243316
Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial
NCT06411431
Negative Pleural Suction for Tube Thoracostomy in Patients With Chest Trauma
NCT01864577
ThOracoscopic Wedge Resection Treated With Chest Tube Removal Intraoperatively
NCT02829736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No chest tube
No chest tube left in the pleural cavity at the end of a VATS pulmonary wedge resection.
Do not leave a chest tube in the pleural cavity.
At the end of a VATS wedge resection, an air leak proof will take place and if no air leak is noted, the surgical incisions for thoracoscopy ports will be closed without leaving a chest tube inserted in the pleural cavity of the patient.
Chest tube
Chest tube left in the pleural cavity at the end of a VATS pulmonary wedge resection.
Do leave a chest tube in the pleural cavity.
At the end of a VATS wedge resection, a chest tube will be inserted in the pleural cavity of the patient through the inferior surgical incision for thoracoscopy port; the rest of the incisions will be closed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Do not leave a chest tube in the pleural cavity.
At the end of a VATS wedge resection, an air leak proof will take place and if no air leak is noted, the surgical incisions for thoracoscopy ports will be closed without leaving a chest tube inserted in the pleural cavity of the patient.
Do leave a chest tube in the pleural cavity.
At the end of a VATS wedge resection, a chest tube will be inserted in the pleural cavity of the patient through the inferior surgical incision for thoracoscopy port; the rest of the incisions will be closed.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No evidence of air leak at the end of the surgical procedure.
* No active bleeding at the end of the surgical procedure.
Exclusion Criteria
* Bullous or emphysematous changes in lung parenchyma.
* Patients going to positive pressure in the airways after the procedure.
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Industrial de Santander
OTHER
Clinica Chicamocha
UNKNOWN
Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Leonidas Tapias, MD
Role: PRINCIPAL_INVESTIGATOR
Fundacion Oftalmológica de Santander Clinica Carlos Ardila Lulle
Luis C Orozco-Vargas, MD
Role: PRINCIPAL_INVESTIGATOR
Universidad Industrial de Santander
Luis F Tapias-Vargas
Role: STUDY_CHAIR
Universidad Industrial de Santander
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundacion Santa Fe de Bogota
Bogotá, Bogota D.C., Colombia
Clinica Chicamocha
Bucaramanga, Santander Department, Colombia
Fundacion Oftalmológica de Santander Clinica Carlos Ardila Lulle
Floridablanca, Santander Department, Colombia
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9009001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.